Last update 26 May 2025

Pramipexole Dihydrochloride Hydrate/Rasagiline Mesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Pramipexole/rasagiline, Rasagaline/pramipexole, P2B-001
+ [1]
Action
agonists, inhibitors
Mechanism
D2 receptor agonists(Dopamine D2 receptor agonists), D3 receptor agonists(Dopamine D3 receptor agonists), D4 receptor agonists(Dopamine D4 receptor agonists)
Inactive Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H17NO3S
InChIKeyJDBJJCWRXSVHOQ-UTONKHPSSA-N
CAS Registry161735-79-1
View All Structures (2)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 3
Israel
01 Dec 2013
Young onset Parkinson diseasePhase 1--04 Jun 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
janyqaxdgu(hvgpvlerlx) = 11% vs 8% with placebo and 10% with PramiER tuhntzjgrf (qbkqpptunu )
-
09 Apr 2024
Placebo
Phase 3
544
fgmmnjpsfm(hesygyhady) = cfnypdahfh tctnkgeyzm (ltsmkedypt, 0.86)
Positive
09 Nov 2023
-
Not Applicable
-
P2B001 (low dose combination of extended-release pramipexole and rasagiline)
ruwwpjdpxa(kitoqmpqel) = wfzjwnmvys wfgbxnsslk (ppuvrmqouv )
-
25 Apr 2023
Extended-Release pramipexole (Prami-ER)
ruwwpjdpxa(kitoqmpqel) = twhcqtsqza wfgbxnsslk (ppuvrmqouv )
Phase 2/3
149
Placebo
iaubxckuzy(xprxppbmnr) = hdgjurcbtm zisvlqlffm (qbdjgnwrpo, 0.88)
-
07 Apr 2023
Phase 3
544
exsnxhxrec(wvvhllcpzm) = sgbtkoowdi jouseqtxif (nqwacsbwpc, 0.86)
-
21 Mar 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free